In 2025, CINDE supported 19 new foreign investment projects and 48 reinvestment projects in Costa Rica. Between 2026 and 2028, 14 confirmed MedTech projects will begin operations. But the work doesn't end there. As global industries continue to evolve, the country is looking beyond its current success to identify new opportunities in increasingly specialized activities.
This challenge is precisely what Marianela Urgellés, CINDE's Managing Director, explores alongside The European in its latest article, Costa Rica looks to Europe for next wave of foreign investment. The feature examines how the country is positioning itself to diversify investment attraction efforts, with a growing focus on European investors in strategic areas such as medical technology, semiconductors, and advanced digital services.
"As companies rethink their global operations, Costa Rica's opportunity lies in combining world-class talent with a mature and increasingly specialized ecosystem. We are taking a targeted approach at closing value chain gaps to strengthen competitiveness and to support the growth of companies already established here," states Urgellés.
This vision will guide CINDE's participation at Electronica and MEDICA in Germany, where our Investment Advisory team will engage with global key actors and present Costa Rica's evolving capabilities to foster the partnerships that will support the next wave of growth.
Contact invest@cinde.org to learn how Costa Rica's proven track record can support your company's growth.
About CINDE
CINDE is the strategic expert and guide for investment in Costa Rica. Since 1982, it has supported multinational companies throughout their establishment, growth, and reinvestment processes in the country. Recognized nationally and internationally as the key private player in Costa Rica’s investment ecosystem, CINDE has independently and as a non-profit organization supported the establishment of more than 400 multinational companies and has a solid network of more than 65 Strategic Allies.